威斯康星州的一场听证会聚焦了科尔法案，该法案旨在改革PBM，因为一名年轻人因难以负担的药费去世。 A Wisconsin hearing spotlighted Cole’s Act, a bill aiming to reform PBMs after a young man died due to unaffordable medication costs.

在立法会议即将结束之际,威斯康辛州公共听证会加紧呼吁通过《科尔法案》,这是一项针对药房福利管理人员的两党法案。 A Wisconsin public hearing intensified calls to pass Cole’s Act, a bipartisan bill targeting pharmacy benefit managers (PBMs), as the legislative session nears its end. 包括22岁的Cole Schmidtknecht家庭在内的倡导者们作证说,PBM报导改变后,药物价格突然上涨,造成致命后果,Cole在买不起500美元的吸入器后死于哮喘病。 Advocates, including the family of 22-year-old Cole Schmidtknecht, testified about the deadly consequences of sudden drug cost spikes after PBM coverage changes, with Cole dying from an asthma attack after being unable to afford a $500 inhaler. 该法案将要求PBM公司在改变药物等级之前提供预先通知,并保护病人和独立药店。 The bill would require PBMs to provide advance notice before altering drug tiers and protect patients and independent pharmacies. PBM反对者辩论的是制造商, 而不是PBM、驱动成本, 并主张帐单不会降低价格。 PBM opponents argue manufacturers, not PBMs, drive costs and claim the bill won’t lower prices. 随着时间的流逝,通过似乎不太可能,但倡导者们誓言继续推动改革。 With time running out, passage seems unlikely, but advocates vow to keep pushing for reform. 与此同时,密西西比众议院也通过了一项类似的PBM改革法案,以结束伤害小药店、旨在刺激竞争和准入的金融“后卫”法案。 Meanwhile, Mississippi’s House passed a similar PBM reform bill to end financial "clawbacks" that harm small pharmacies, aiming to boost competition and access.